Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest Post author:Sam Post published:November 29, 2017 Post category:BioPharma The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments. Source: BioSpace You Might Also Like The Medicines Company To Announce Fourth-Quarter And Full-Year 2016 Financial Results On February 28, 2017 February 16, 2017 Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular August 23, 2017 Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017
The Medicines Company To Announce Fourth-Quarter And Full-Year 2016 Financial Results On February 28, 2017 February 16, 2017
Incyte Release: Combination Of Epacadostat Plus Keytruda (Pembrolizumab) Demonstrates Activity In Clinical Trial Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) June 4, 2017
